AAAAAA
Results:
1-14
|
Results: 14
Authors:
EINSELE H
BAMBERG M
BUDACH H
SCHMIDT H
HEBART H
TRUMPER L
LOFFLER B
HOFFMANN A
SCHLIMOK G
HERTENSTEIN B
PEEST D
GANSER A
METZNER B
FRICKHOFEN N
FAUL C
BRUGGER W
KANZ L
Citation: H. Einsele et al., PHASE I II TRIAL OF TOTAL MARROW IRRADIATION, BUSULFAN AND CYCLOPHOSPHAMIDE FOLLOWED BY PERIPHERAL AUTOLOGOUS PBSCT IN PATIENTS WITH ADVANCED MULTIPLE-MYELOMA/, Experimental hematology, 25(8), 1997, pp. 427-427
Authors:
PEEST D
DEICHER H
FETT W
HARMS P
BRAUN HJ
PLANKER M
KINDLER U
KLINKENSTEIN C
SCHAFER E
SCHUMACHER K
SIECKE H
Citation: D. Peest et al., PYRIDINIUM CROSS-LINKS IN MULTIPLE-MYELOMA - CORRELATION WITH CLINICAL-PARAMETERS AND USE FOR MONITORING OF INTRAVENOUS CLODRONATE THERAPY - A PILOT-STUDY OF THE GERMAN MYELOMA TREATMENT GROUP (GMTG), European journal of cancer, 32A(12), 1996, pp. 2053-2057
Authors:
JOHANNES S
GORKE T
JOBGES ME
DILLO W
BLAUTH M
PEEST D
MUNTE TF
DENGLER R
Citation: S. Johannes et al., CHRONIC BACK PAIN - OSTEOPOROSIS VERSUS N ONSECRETORY MULTIPLE-MYELOMA, Aktuelle Neurologie, 23(4), 1996, pp. 176-178
Authors:
PEEST D
BLADE J
HAROUSSEAU JL
KLEIN B
OSTERBORG A
SANMIGUEL JF
Citation: D. Peest et al., CYTOKINE THERAPY IN MULTIPLE-MYELOMA, British Journal of Haematology, 94(3), 1996, pp. 425-432
Authors:
OSTERBORG A
BOOGAERTS MA
CIMINO R
ESSERS U
HOLOWIECKI J
JULIUSSON G
JAGER G
NAJMAN A
PEEST D
Citation: A. Osterborg et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN IN TRANSFUSION-DEPENDENT ANEMIC PATIENTS WITH MULTIPLE-MYELOMA AND NON-HODGKINS-LYMPHOMA - A RANDOMIZED MULTICENTER STUDY, Blood, 87(7), 1996, pp. 2675-2682
Authors:
PEEST D
LEO R
DEICHER H
Citation: D. Peest et al., TUMOR-DIRECTED CYTOTOXICITY IN MULTIPLE-MYELOMA - THE BASIS FOR AN EXPERIMENTAL TREATMENT APPROACH WITH INTERLEUKIN-2, Stem cells, 13, 1995, pp. 72-76
Authors:
PEEST D
DEICHER H
COLDEWEY R
LEO R
BARTL R
BARTELS H
BRAUN HJ
FETT W
FISCHER JT
GOBEL B
HARMS P
HENKE R
HOFFMANN L
KREUSER ED
MAIER WD
MEIER CR
OERTEL J
PETIT M
PLANKER M
PLATZECK C
RESPONDEK M
SCHAFER E
SCHUMACHER K
STENNES M
STENZINGER W
TIRIER C
WAGNER H
WEH HJ
VONWUSSOW P
WYSK J
Citation: D. Peest et al., A COMPARISON OF POLYCHEMOTHERAPY AND MELPHALAN PREDNISONE FOR PRIMARYREMISSION INDUCTION, AND INTERFERON-ALPHA FOR MAINTENANCE TREATMENT, IN MULTIPLE-MYELOMA - A PROSPECTIVE TRIAL OF THE GERMAN MYELOMA TREATMENT GROUP, European journal of cancer, 31A(2), 1995, pp. 146-151
Authors:
SAILER M
VYKOUPIL KF
PEEST D
COLDEWEY R
DEICHER H
GEORGII A
Citation: M. Sailer et al., PROGNOSTIC RELEVANCE OF A HISTOLOGIC CLASSIFICATION-SYSTEM APPLIED INBONE-MARROW BIOPSIES FROM PATIENTS WITH MULTIPLE-MYELOMA - A HISTOPATHOLOGICAL EVALUATION OF BIOPSIES FROM 153 UNTREATED PATIENTS, European journal of haematology, 54(3), 1995, pp. 137-146
Authors:
QUESADA S
LEO R
DEICHER H
PEEST D
Citation: S. Quesada et al., FUNCTIONAL AND BIOCHEMICAL CHARACTERISTICS OF A SOLUBLE B-LYMPHOCYTE PROLIFERATION-INHIBITING ACTIVITY PRODUCED BY BONE-MARROW CELLS FROM MULTIPLE-MYELOMA PATIENTS, Cellular immunology, 162(2), 1995, pp. 275-281
Authors:
PEEST D
LEO R
BLOCHE S
HEIN R
STANNATKIESSLING S
TSCHECHNE B
FETT W
HARMS P
HOFFMANN L
BARTL R
WACKER HH
GORG S
ATZPODIEN J
KIRCHNER H
DEICHER H
Citation: D. Peest et al., LOW-DOSE RECOMBINANT INTERLEUKIN-2 THERAPY IN ADVANCED MULTIPLE-MYELOMA, British Journal of Haematology, 89(2), 1995, pp. 328-337
Authors:
BUGLIOSI R
TRIBALTO M
BOCCADORO M
PEEST D
CARATOZZOLO A
PETRUCCI MT
AMADORI S
Citation: R. Bugliosi et al., PROGNOSTIC CLASSIFICATION OF MULTIPLE-MYELOMA PATIENTS BY USING A NEURAL-NETWORK SOFTWARE, Blood, 86(10), 1995, pp. 3310-3310
Authors:
PEEST D
DEICHER H
Citation: D. Peest et H. Deicher, NON-HODGKIN-LYMPHOMA IN HEART LUNG TRANSPLANT RECIPIENTS/, Lancet, 343(8895), 1994, pp. 481-482
Authors:
PEEST D
COLDEWEY R
DEICHER H
SAILER M
VYKOUPIL C
LEO R
GEORGII A
KAROW J
HOEPPNER E
DIEHL V
ESSERS U
GAMM H
GLUCK S
GORG K
GRAMATZKI M
HAUSWALDT C
HEILMANN E
HIEMEYER V
KEYSERLINGK HJ
KINDLER A
OERTEL J
PLANKER M
REINOLD HM
SCHAFER E
SCHUMACHER K
TIRIER C
URBANITZ D
SUCHY BR
WAHRISCH J
Citation: D. Peest et al., PROGNOSTIC VALUE OF CLINICAL, LABORATORY, AND HISTOLOGICAL CHARACTERISTICS IN MULTIPLE-MYELOMA - IMPROVED DEFINITION OF RISK GROUPS, European journal of cancer, 29A(7), 1993, pp. 978-983
Authors:
LINK H
BRUNE T
HUBNER G
DIEDRICH H
FREUND M
STOLL M
PEEST D
EBELL W
BETTONI C
OSTER W
NICOLAY U
HEINRICHS H
Citation: H. Link et al., EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Annals of hematology, 67(4), 1993, pp. 169-173
Risultati:
1-14
|